Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

OS Therapies Inc

NYSE: OSTX · Life Sciences · 3 alerts · CIK 1795091

Share price
$0.6807Close, Nov 16
Market cap
$35.6M
Shares outstanding
52.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All OS Therapies Inc filings on SEC EDGAR ↗

4:38 PM ET 8-K
Leadership Change

OS Therapies Leadership Change

OS Therapies appointed Frank Knuettel II as Chief Financial Officer and Kerry Clem as Chief Commercial Officer, effective September 29, 2026. Mr. Knuettel succeeds Christopher P. Acevedo, who will transition to a consulting role, while Mr. Clem will lead the commercialization strategy for the company's lead product candidate, Herlystic.

Term
3 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.